We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance

Results:1-10 of 201

New York AG Takes Enforcement Action Against Heart Monitoring Apps: Murmurs of Concern are Heard in mHealth App World
  • Sheppard Mullin Richter & Hampton LLP
  • USA
  • April 5 2017

In a move sure to cause murmurs in the large and growing mobile health application industry, the Office of New York Attorney General Eric Schneiderman

New anti-bribery law for the healthcare sector in Germany (June 2016 update)
  • Taylor Wessing
  • Germany
  • June 24 2016

In its cabinet session on 14 April 2016, the German government adopted a bill on combating corruption in the healthcare sector. Before, the committee

House bill proposes to repeal the learned intermediary doctrine
  • Baker Donelson Bearman Caldwell & Berkowitz PC
  • USA
  • February 11 2011

On February 8, 2011, Representative Bob Filner (D-CA) introduced legislation that could dramatically change the products liability landscape for pharmaceutical and medical device manufacturers.

FDA issues final Good Reprint Practices guidance
  • Hogan Lovells
  • USA
  • January 13 2009

On January 13, 2008, the U.S. Food and Drug Administration (FDA) issued its final “Good Reprint Practices” guidance regarding the distribution of medical or scientific journal articles and reference publications that involve unapproved (off-label) uses of FDA-approved drugs and medical devices.

Amanda Turnill
  • Clayton Utz